Lv2
140 积分 2024-04-18 加入
Ritlecitinib: an investigational drug for the treatment of moderate to severe alopecia areata
2个月前
已完结
A multicenter, randomized, double-blinded, placebo-controlled, phase Ⅲ study evaluating the efficacy and safety of Xeligekimab (GR1501) in patients with moderate-to-severe plaque psoriasis
4个月前
已完结
Effects of blood sample mishandling on ELISA results for infectious bronchitis virus, avian encephalomyelitis virus and chicken anaemia virus
5个月前
已完结
Population Pharmacokinetics of Semaglutide for Type 2 Diabetes
5个月前
已完结
Standardized Methods for Detection of Poliovirus Antibodies
5个月前
已完结
A first-in-human phase 1 study of a novel PARP7 inhibitor RBN-2397 in patients with advanced solid tumors
5个月前
已关闭
Serum GDNF levels as predictors of subjective cognitive complaints in male subjects with major depressive disorder
6个月前
已完结
Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial
8个月前
已完结
Secukinumab long-term safety experience: A pooled analysis of 10 phase II and III clinical studies in patients with moderate to severe plaque psoriasis
8个月前
已完结
皖公网安备34019202002308
